Peer AI is an AI-native medical writing platform built for pharmaceutical sponsors and contract research organizations (CROs) . It automates the most demanding class of clinical trial documentation, covering patient narratives, clinical study reports, and regulatory submissions. In that class, accuracy and regulatory compliance are not product features but preconditions, and a hallucinated detail is a compliance exposure rather than a bug.
A platform held to that standard cannot be built by a delivery process held to a lower one. Peer AI built the platform on a Claude-native Software Delivery Lifecycle, embedding Anthropic’s Claude into specification design, pull request review, vulnerability patching, and QA architecture. Routine first-pass review, security-alert grouping, and documentation drafting now run through Claude-assisted workflows, with Peer AI’s engineers retaining approval authority and spending their time on architecture, product decisions, and clinical-domain judgment.
Peer AI’s engineering team builds and runs the platform together with Zemoso, its product engineering partner. The two teams jointly designed and operated the Claude workflows described here.
High-stakes product requirements, compounded by delivery overhead
An enterprise life sciences platform creates intense operational and technical demands across two distinct fronts:
To help Peer AI scale its platform while upholding strict regulatory and architectural discipline, Zemoso and Peer AI jointly engineered solutions for four core technical barriers:
Our clients love what we do:
Peer AI embedded Claude across three operational workstreams, each aimed at one of these constraints directly.
Specification drift is the failure mode that matters most in a regulated domain: a model that does not know a system’s conventions will confidently violate them. Every active repository therefore carries a canonical CLAUDE.md file covering architecture guidelines, coding standards, domain invariants, and explicit anti-patterns. That file is the contract every agent reads before it acts.
Peer AI’s engineers work a structured loop: Plan → LLM-reviewed spec → Implementation → Spec-grounded review. Architecture documents, C4 diagrams, and API specifications that previously took several days are now drafted and reviewed the same day.
A Claude review agent is wired into CI/CD through GitHub Actions and processes pull requests across active repositories before a senior engineer engages. It checks each change against that repository’s CLAUDE.md standards, flagging convention violations, logic gaps, and formatting inconsistencies. Peer AI’s engineers arrive at a pull request already cleared of routine defects, and spend their attention on design and clinical correctness.
Compliance obligations do not pause for the roadmap. Peer AI runs an automated security pipeline on a standing 48-hour cadence, split across two agents:
Building enterprise-grade AI products requires an engineering pipeline as sophisticated as the application itself. By pairing deep platform architecture with a Claude-native SDLC, Peer AI’s engineering team ships a medical writing platform built for regulated use while keeping senior engineering attention on architecture, product judgment, and clinical-domain review. The same pipeline has removed the operational friction that typically slows engineering teams as they scale.
Peer AI builds with Zemoso Technologies, its product engineering partner. The Claude-native SDLC described here was designed and is operated jointly by the Peer AI and Zemoso engineering teams, using Anthropic’s Claude.